Cite

HARVARD Citation

    Tamayo, S. et al. (n.d.). Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban. Clinical cardiology. 38 (2), pp. 63-68. [Online]. 
  
Back to record